Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

China · Delayed Price · Currency is CNY

6.44

+0.03 (0.47%)

Sep 30, 2026, 4:00 PM EDT

Market Cap	1.76B -44.0%
Revenue (ttm)	136.13M +38.6%
Net Income	-134.06M
EPS	-0.49
Shares Out	272.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,729,600
Open	6.40
Previous Close	6.41
Day's Range	6.37 - 6.47
52-Week Range	5.47 - 11.54
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2026

About SHA:688189

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceuti... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 2006

Employees 277

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688189

Full Company Profile

Financial Performance

In 2025, SHA:688189's revenue was 141.93 million, a decrease of -43.62% compared to the previous year's 251.72 million. Losses were -136.90 million, -60.49% less than in 2024.

Financial Statements